| 摘要 |
<P>PROBLEM TO BE SOLVED: To obtain a muscle-strengthening drug treating muscle weakening, inflammation, especially arthritis, an antiinflammatory drug, an anticerebral infarction sequela drug, an antimotor paralytic drug, an antiasthmatic drug, an antivision diminution drug, an antihepatitic drug, antiinflammatory intestinal syndrome drug, an antifunctional enteropathy drug, an antifunctional cardiopathy drug, an antifunctional hepatopathy drug, an antifunctional nephropathy drug, an antidiarrheal drug and an antidementia drug by administering the muscle-strengthening drug or the antiinflammatory drug characterized as comprising an isoflavone and/or an isoflavone glycoside in combination with a pungent substance, a bitter substance or a sour substance and cholic acid and/or scymnol and/or a scymnol ester. <P>SOLUTION: There are provided the muscle-strengthening drug, the antiinflammatory drug or the anticerebral infarction sequela drug, the antimotor paralytic drug, the antiasthmatic drug, the antivision diminution drug, the antihepatitic drug, the inflammatory intestinal syndrome drug, the antifunctional enteropathy drug, the antifunctional cardiopathy drug, the antifunctional hepatopathy drug, the antifunctional nephropathy drug, the antidiarreal drug and the antidementia drug comprising the isoflavone and/or the isoflavone glycoside in combination with the pungent substance, the bitter substance or the sour substance and the cholic acid and the scymnol and/or scymnol. <P>COPYRIGHT: (C)2004,JPO&NCIPI |
